zoledronic acid

The drug is used to treat osteoporosis in postmenopausal women, in men with an increased risk of fractures (including after a recent hip fracture), and to treat osteoporosis caused by long-term glucocorticoid therapy. It is also prescribed for the treatment of Paget's disease in adults.

Form: solution for infusion

ATC: M05BA08

Manufacturer: Novartis Pharma Stein AG (secondary packaging, batch control, batch release)

It is used to prevent bone complications (such as fractures or vertebral compression) in patients with advanced-stage tumors, as well as to treat high calcium levels (hypercalcemia) caused by malignant neoplasms.

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: RAFARM S.A.

The drug is used to prevent bone complications (such as pathological fractures or spinal compression) in patients with advanced-stage tumors. It is also used to treat hypercalcemia caused by malignant tumors.

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: Farmideya LLC

The drug is used to prevent symptoms associated with bone tissue damage (e.g., pathological fractures or spinal compression) in patients with advanced-stage malignancies, as well as to treat tumor-induced hypercalcemia.

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: PJSC "Lekhim-Kharkiv"

The drug is used to prevent symptoms associated with bone tissue damage (e.g., pathological fractures or spinal compression) in patients with advanced-stage malignant neoplasms, as well as to treat tumor-induced hypercalcemia.

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: Moroccan Therapeutic Society (manufacturing, packaging)

The drug is used to prevent bone complications (such as pathological fractures, spinal compression, or hypercalcemia) in patients with advanced-stage tumors, as well as to treat hypercalcemia caused by malignant tumors.

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: Farmex Group LLC

The drug is used to treat hypercalcemia caused by malignant tumors, as well as to prevent complications in patients with advanced-stage tumors (e.g., pathological fractures, spinal compression, or consequences of radiation therapy).

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: Pliva Hrvatska Limited

The drug is used to prevent complications in patients with advanced-stage tumors (such as pathological fractures, spinal compression, or hypercalcemia) and to treat hypercalcemia caused by malignant neoplasms.

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: Moroccan Therapeutic Society (manufacturing, packaging)

It is used for the treatment of osteoporosis in postmenopausal women and in men at high risk of fractures (specifically following a recent hip fracture). The drug is also prescribed for the treatment of Paget's disease of bone in adults and osteoporosis caused by long-term glucocorticoid use.

Form: solution for infusion

ATC: M05BA08

Manufacturer: Evrolife Healthcare Pvt. Ltd.

The drug is used for the treatment of osteoporosis in postmenopausal women and in men at high risk of fractures. It is also prescribed for the treatment of Paget's disease in adults.

Form: solution for infusion

ATC: M05BA08

Manufacturer: Altan Pharmaceuticals, S.A.

It is used for the prevention of bone complications (e.g., pathological fractures or spinal compression) in patients with advanced-stage tumors, as well as for the treatment of high calcium levels (hypercalcemia) caused by malignant neoplasms.

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: Hetero Labs Limited

The drug is used for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also prescribed for the treatment of Paget's disease of bone in adults and osteoporosis caused by long-term glucocorticoid use.

Form: solution for infusion

ATC: M05BA08

Manufacturer: Mefar Ilac San. A.S.

The drug is used to prevent symptoms associated with bone damage (e.g., pathological fractures or spinal compression) in patients with advanced-stage malignant neoplasms. It is also prescribed for the treatment of tumor-induced hypercalcemia.

Form: concentrate for infusion solution

ATC: M05BA08

Manufacturer: Novartis Pharma Stein AG (full-cycle manufacturing)